AAPL Apple | $223.66
-0.1% | 1/23/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $325.00 -> $325.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 1/23/2025 |
EA Electronic Arts | $118.58
-16.7% | 1/23/2025 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $173.00 -> $173.00 | High | View details for Wedbush rating of Electronic Arts (NASDAQ:EA) on 1/23/2025 |
PLTR Palantir Technologies | $78.98
+2.7% | 1/23/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $75.00 -> $90.00 | Medium | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 1/23/2025 |
SNOW Snowflake | $174.77
-1.5% | 1/21/2025 | Upgraded by | Wedbush | Analyst D. Ives | Hold -> Strong-Buy | | Low | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 1/21/2025 |
LOGI Logitech International | $91.55
+4.2% | 1/22/2025 | Reiterated by | Wedbush | - | Neutral | $88.00 | High | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 1/22/2025 |
STX Seagate Technology | $108.42
+0.2% | 1/22/2025 | Reiterated by | Wedbush | - | Outperform | $150.00 | Low | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 1/22/2025 |
NFLX Netflix | $984.86
+3.2% | 1/22/2025 | Reiterated by | Wedbush | - | Outperform | $950.00 -> $1,150.00 | High | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 1/22/2025 |
META Meta Platforms | $636.45
+2.1% | 1/22/2025 | Reiterated by | Wedbush | Analyst Meta Marshall | Outperform -> Outperform | $680.00 -> $700.00 | Medium | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 1/22/2025 |
TSLA Tesla | $412.38
-0.7% | 1/22/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $515.00 -> $550.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 1/22/2025 |
CMG Chipotle Mexican Grill | $57.58
+3.0% | 1/22/2025 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $69.00 -> $69.00 | Medium | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 1/22/2025 |
|
IRON Disc Medicine | $56.99
-2.6% | 1/21/2025 | Reiterated by | Wedbush | - | Outperform | $83.00 -> $90.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 1/21/2025 |
DHI D.R. Horton | $145.25
-1.1% | 1/17/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $180.00 | Low | View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 1/17/2025 |
IMAX IMAX | $23.74
+1.1% | 1/17/2025 | Reiterated by | Wedbush | - | Outperform | $32.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 1/17/2025 |
KROS Keros Therapeutics | $12.02
+5.5% | 1/17/2025 | Downgraded by | Wedbush | Analyst Y. Zhong | Outperform -> Neutral | $47.00 -> $15.00 | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 1/17/2025 |
PZZA Papa Johns International | $39.88
+5.5% | 1/15/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $60.00 -> $60.00 | Medium | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 1/15/2025 |
SHAK Shake Shack | $121.53
+0.3% | 1/15/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $130.00 -> $130.00 | Low | View details for Wedbush rating of Shake Shack (NYSE:SHAK) on 1/15/2025 |
CATX Perspective Therapeutics | $3.63
+0.8% | 1/13/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $11.00 | High | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 1/13/2025 |
KNSA Kiniksa Pharmaceuticals | $19.77
+2.9% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $34.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 1/13/2025 |
NVCR NovoCure | $27.02
+0.7% | 1/13/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral | $29.00 | High | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 1/13/2025 |
SWTX SpringWorks Therapeutics | $36.14
+3.3% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $77.00 | High | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/13/2025 |
NUVL Nuvalent | $83.70
+2.9% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $115.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 1/13/2025 |
BEAM Beam Therapeutics | $26.29
-0.4% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $57.00 | High | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 1/13/2025 |
SYRE Spyre Therapeutics | $21.81
0.0% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $65.00 | Medium | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 1/13/2025 |
ORIC ORIC Pharmaceuticals | $10.34
+4.8% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $20.00 | High | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 1/13/2025 |
IMNM Immunome | $10.22
+0.1% | 1/13/2025 | Reiterated by | Wedbush | - | Outperform | $33.00 | Medium | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 1/13/2025 |
COGT Cogent Biosciences | $8.89
+8.4% | 1/13/2025 | Reiterated by | Wedbush | - | Neutral | $11.00 | High | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 1/13/2025 |
UMH UMH Properties | $17.98
+0.0% | 1/13/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Neutral -> Neutral | $20.00 -> $20.00 | Medium | View details for Wedbush rating of UMH Properties (NYSE:UMH) on 1/13/2025 |
RARE Ultragenyx Pharmaceutical | $44.85
+4.4% | 1/13/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Neutral -> Neutral | $46.00 -> $48.00 | High | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 1/13/2025 |
BPMC Blueprint Medicines | $115.63
+4.1% | 1/13/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $135.00 -> $124.00 | High | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 1/13/2025 |
INZY Inozyme Pharma | $1.32
+1.5% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $12.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 1/10/2025 |
IRON Disc Medicine | $56.99
-2.6% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $83.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 1/10/2025 |
MRSN Mersana Therapeutics | $0.52
-1.3% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $7.00 -> $4.00 | Low | View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 1/10/2025 |
ITOS iTeos Therapeutics | $7.67
-0.5% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $25.00 | Low | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 1/10/2025 |
NTLA Intellia Therapeutics | $11.29
+2.5% | 1/10/2025 | Reiterated by | Wedbush | - | Neutral | $14.00 -> $10.00 | Low | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 1/10/2025 |
YMAB Y-mAbs Therapeutics | $6.28
+1.5% | 1/10/2025 | Reiterated by | Wedbush | - | Outperform | $23.00 | Low | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 1/10/2025 |
IGMS IGM Biosciences | $1.72
+1.2% | 1/10/2025 | Reiterated by | Wedbush | Analyst R. Driscoll | Outperform -> Neutral | $22.00 -> $3.00 | High | View details for Wedbush rating of IGM Biosciences (NASDAQ:IGMS) on 1/10/2025 |
VICI VICI Properties | $29.32
-0.5% | 1/8/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Strong-Buy -> Hold | | Medium | View details for Wedbush rating of VICI Properties (NYSE:VICI) on 1/8/2025 |
BXP Boston Properties | $71.92
-1.1% | 1/8/2025 | Upgraded by | Wedbush | Analyst R. Anderson | Strong Sell -> Hold | | High | View details for Wedbush rating of Boston Properties (NYSE:BXP) on 1/8/2025 |
SRRK Scholar Rock | $45.40
-2.8% | 1/9/2025 | Reiterated by | Wedbush | - | Outperform | $47.00 | Low | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 1/9/2025 |
ROKU Roku | $83.78
+5.3% | 1/8/2025 | Reiterated by | Wedbush | - | Outperform | $100.00 | High | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 1/8/2025 |
Elon Musk’s FINAL Move (Ad) I call it "Elon's Final Move" because his new AI venture will dominate Tesla... Get all the details here >>> |
LGIH LGI Homes | $91.69
-1.6% | 1/7/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $125.00 -> $115.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 1/7/2025 |
MTH Meritage Homes | $82.06
+0.0% | 1/7/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $205.00 -> $103.00 | Medium | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 1/7/2025 |
GETY Getty Images | $2.58
-4.3% | 1/7/2025 | Reiterated by | Wedbush | - | Outperform | $7.70 | High | View details for Wedbush rating of Getty Images (NYSE:GETY) on 1/7/2025 |
NUVB Nuvation Bio | $2.77
+4.3% | 1/6/2025 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 1/6/2025 |
RH RH | $435.07
-1.7% | 1/6/2025 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $500.00 | N/A | View details for Wedbush rating of RH (NYSE:RH) on 1/6/2025 |
GOOGL Alphabet | $197.98
-0.2% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $210.00 -> $220.00 | N/A | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 1/6/2025 |
MELI MercadoLibre | $1,828.73
+0.6% | 1/6/2025 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $2,200.00 -> $2,100.00 | N/A | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 1/6/2025 |
BKNG Booking | $4,818.14
+4.3% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5,000.00 -> $5,500.00 | N/A | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 1/6/2025 |
LYFT Lyft | $13.60
+1.3% | 1/6/2025 | Target Lowered by | Wedbush | Analyst S. Devitt | Neutral -> Neutral | $20.00 -> $18.00 | N/A | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 1/6/2025 |
TTD Trade Desk | $119.14
-1.3% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $135.00 -> $145.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 1/6/2025 |
META Meta Platforms | $636.45
+2.1% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $640.00 -> $680.00 | N/A | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 1/6/2025 |
W Wayfair | $48.02
+0.6% | 1/6/2025 | Downgraded by | Wedbush | Analyst S. Basham | Outperform -> Neutral | $45.00 -> $44.00 | N/A | View details for Wedbush rating of Wayfair (NYSE:W) on 1/6/2025 |
AMZN Amazon.com | $235.42
+0.2% | 1/6/2025 | Target Raised by | Wedbush | - | Outperform -> Outperform | $250.00 -> $260.00 | N/A | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 1/6/2025 |
STRW Strawberry Fields REIT | $11.10
+2.2% | 1/6/2025 | Initiated by | Wedbush | Analyst R. Anderson | Outperform | $12.00 | N/A | View details for Wedbush rating of Strawberry Fields REIT (NYSEAMERICAN:STRW) on 1/6/2025 |
SHOP Shopify | $106.16
-0.2% | 1/6/2025 | Upgraded by | Wedbush | Analyst S. Devitt | Neutral -> Outperform | $115.00 -> $125.00 | N/A | View details for Wedbush rating of Shopify (NYSE:SHOP) on 1/6/2025 |
PHM PulteGroup | $116.56
-0.3% | 1/3/2025 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of PulteGroup (NYSE:PHM) on 1/3/2025 |
PEB Pebblebrook Hotel Trust | $13.99
-0.2% | 1/2/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Neutral -> Underperform | $13.00 | N/A | View details for Wedbush rating of Pebblebrook Hotel Trust (NYSE:PEB) on 1/2/2025 |
HR Healthcare Realty Trust | $16.74
+1.6% | 1/2/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Neutral -> Underperform | $18.00 -> $16.00 | N/A | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 1/2/2025 |
CTRE CareTrust REIT | $26.72
+1.0% | 1/2/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Neutral -> Underperform | $34.00 -> $26.00 | N/A | View details for Wedbush rating of CareTrust REIT (NASDAQ:CTRE) on 1/2/2025 |
BXP Boston Properties | $71.92
-1.1% | 1/2/2025 | Downgraded by | Wedbush | Analyst R. Anderson | Neutral -> Underperform | $81.00 -> $70.00 | N/A | View details for Wedbush rating of Boston Properties (NYSE:BXP) on 1/2/2025 |
VICI VICI Properties | $29.32
-0.5% | 1/2/2025 | Upgraded by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $34.00 -> $33.00 | N/A | View details for Wedbush rating of VICI Properties (NYSE:VICI) on 1/2/2025 |
DEI Douglas Emmett | $17.13
-1.7% | 1/2/2025 | Upgraded by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $19.00 -> $21.00 | N/A | View details for Wedbush rating of Douglas Emmett (NYSE:DEI) on 1/2/2025 |
RCKT Rocket Pharmaceuticals | $11.08
+5.7% | 12/30/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $32.00 | N/A | View details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 12/30/2024 |
AAPL Apple | $223.66
-0.1% | 12/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $300.00 -> $325.00 | N/A | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/26/2024 |
TCRX TScan Therapeutics | $2.56
+1.6% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $7.00 | N/A | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 12/23/2024 |
NUVB Nuvation Bio | $2.77
+4.3% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 12/23/2024 |
IKNA Ikena Oncology | $1.46
-0.7% | 12/23/2024 | Reiterated by | Wedbush | - | Neutral | $2.00 | N/A | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 12/23/2024 |
SIMO Silicon Motion Technology | $53.96
-0.1% | 12/23/2024 | Reiterated by | Wedbush | - | Outperform | $90.00 | N/A | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 12/23/2024 |
BZH Beazer Homes USA | $27.94
-0.2% | 12/23/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $45.00 | N/A | View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 12/23/2024 |
FENC Fennec Pharmaceuticals | $6.02
+5.1% | 12/20/2024 | Reiterated by | Wedbush | - | Outperform | $13.00 | N/A | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 12/20/2024 |
DRI Darden Restaurants | $186.22
+0.3% | 12/20/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $200.00 -> $220.00 | N/A | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 12/20/2024 |
XMTR Xometry | $33.25
+0.7% | 12/20/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform | $48.00 | N/A | View details for Wedbush rating of Xometry (NASDAQ:XMTR) on 12/20/2024 |
LAC Lithium Americas | C$4.56
+2.5% | 12/19/2024 | Upgraded by | Wedbush | Analyst D. Ives | Hold | | N/A | View details for Wedbush rating of Lithium Americas (TSE:LAC) on 12/19/2024 |
SNOW Snowflake | $174.77
-1.5% | 12/18/2024 | Downgraded by | Wedbush | Analyst D. Ives | Strong-Buy -> Hold | | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 12/18/2024 |
ESTC Elastic | $104.15
+2.9% | 12/18/2024 | Downgraded by | Wedbush | Analyst D. Ives | Strong-Buy -> Hold | | N/A | View details for Wedbush rating of Elastic (NYSE:ESTC) on 12/18/2024 |
VTR Ventas | $59.46
+1.9% | 12/19/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | N/A | View details for Wedbush rating of Ventas (NYSE:VTR) on 12/19/2024 |
TRIP Tripadvisor | $17.93
+13.9% | 12/19/2024 | Reiterated by | Wedbush | - | Neutral | $17.00 | N/A | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 12/19/2024 |
LEN Lennar | $134.45
-1.2% | 12/19/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $164.00 -> $164.00 | N/A | View details for Wedbush rating of Lennar (NYSE:LEN) on 12/19/2024 |
HMST HomeStreet | $10.41
-2.9% | 12/19/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $12.00 -> $15.00 | N/A | View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 12/19/2024 |
TTD Trade Desk | $119.14
-1.3% | 12/19/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 12/19/2024 |
INOD Innodata | $39.68
-0.3% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $48.00 | N/A | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 12/19/2024 |
LAC Lithium Americas | $3.18
+2.1% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Neutral | $5.00 | N/A | View details for Wedbush rating of Lithium Americas (NYSE:LAC) on 12/19/2024 |
OKLO Oklo | $38.76
+13.4% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $26.00 | N/A | View details for Wedbush rating of Oklo (NYSE:OKLO) on 12/19/2024 |
SWI SolarWinds | $14.62
0.0% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $20.00 | N/A | View details for Wedbush rating of SolarWinds (NYSE:SWI) on 12/19/2024 |
OS Onestream | $30.35
+1.9% | 12/19/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $40.00 | N/A | View details for Wedbush rating of Onestream (NASDAQ:OS) on 12/19/2024 |
TXRH Texas Roadhouse | $179.13
-0.5% | 12/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $200.00 -> $200.00 | N/A | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/19/2024 |
MNRO Monro | $21.60
-0.3% | 12/18/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $31.00 | N/A | View details for Wedbush rating of Monro (NASDAQ:MNRO) on 12/18/2024 |
BLDR Builders FirstSource | $168.26
+1.5% | 12/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $230.00 -> $230.00 | N/A | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 12/18/2024 |
CRM Salesforce | $334.75
+0.6% | 12/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $425.00 -> $425.00 | N/A | View details for Wedbush rating of Salesforce (NYSE:CRM) on 12/18/2024 |
MU Micron Technology | $104.84
-4.0% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $140.00 -> $140.00 | N/A | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 12/17/2024 |
DeFi Coin on Verge of Breakout! (Ad) What Smart Crypto Investors Are Doing Differently in 2025
Free book reveals how to navigate and thrive in today’s crypto market…
 Request your FREE copy of Crypto Revolution now. |
CSR Centerspace | $61.27
+0.9% | 12/17/2024 | Initiated by | Wedbush | Analyst R. Anderson | Neutral | $72.00 | N/A | View details for Wedbush rating of Centerspace (NYSE:CSR) on 12/17/2024 |
GEO The GEO Group | $33.51
-2.5% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | | N/A | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 12/17/2024 |
IDYA IDEAYA Biosciences | $23.29
+0.6% | 12/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $52.00 -> $52.00 | N/A | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 12/17/2024 |
NBIX Neurocrine Biosciences | $147.58
+0.6% | 12/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $148.00 -> $148.00 | N/A | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 12/16/2024 |
SOUN SoundHound AI | $16.40
+0.1% | 12/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $10.00 -> $22.00 | N/A | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 12/16/2024 |
HOV Hovnanian Enterprises | $138.70
-0.7% | 12/16/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $155.00 | N/A | View details for Wedbush rating of Hovnanian Enterprises (NYSE:HOV) on 12/16/2024 |
SLDB Solid Biosciences | $3.00
-3.8% | 12/12/2024 | Upgraded by | Wedbush | Analyst L. Chico | Strong-Buy | | N/A | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 12/12/2024 |
RH RH | $435.07
-1.7% | 12/13/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $430.00 -> $500.00 | N/A | View details for Wedbush rating of RH (NYSE:RH) on 12/13/2024 |
SLDB Solid Biosciences | $3.00
-3.8% | 12/13/2024 | Initiated by | Wedbush | - | Outperform | $16.00 | N/A | View details for Wedbush rating of Solid Biosciences (NASDAQ:SLDB) on 12/13/2024 |
PZZA Papa Johns International | $39.88
+5.5% | 12/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 -> $60.00 | N/A | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 12/13/2024 |
ITOS iTeos Therapeutics | $7.67
-0.5% | 12/12/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 | N/A | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 12/12/2024 |
TTD Trade Desk | $119.14
-1.3% | 12/12/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 12/12/2024 |
LEN Lennar | $134.45
-1.2% | 12/12/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $164.00 -> $164.00 | N/A | View details for Wedbush rating of Lennar (NYSE:LEN) on 12/12/2024 |
LOW Lowe's Companies | $261.16
+1.2% | 12/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $250.00 -> $250.00 | N/A | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 12/12/2024 |
ANAB AnaptysBio | $16.63
+2.8% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 -> $40.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 12/11/2024 |
DBD Diebold Nixdorf | $44.29
-1.1% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $50.00 -> $60.00 | N/A | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 12/11/2024 |
ASO Academy Sports and Outdoors | $55.46
+1.3% | 12/11/2024 | Reiterated by | Wedbush | - | Outperform | $65.00 | N/A | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 12/11/2024 |
TOL Toll Brothers | $136.58
+0.3% | 12/11/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | N/A | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 12/11/2024 |
VIRC Virco Mfg. | $11.15
+0.5% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 -> $17.00 | N/A | View details for Wedbush rating of Virco Mfg. (NASDAQ:VIRC) on 12/10/2024 |
CMRX Chimerix | $3.83
+1.3% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 12/10/2024 |
TCRX TScan Therapeutics | $2.56
+1.6% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 -> $7.00 | N/A | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 12/10/2024 |
STRO Sutro Biopharma | $2.03
+3.0% | 12/10/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | N/A | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 12/10/2024 |
CXW CoreCivic | $21.68
-2.5% | 12/10/2024 | Upgraded by | Wedbush | Analyst J. Mccanless | Neutral -> Outperform | $19.00 -> $30.00 | N/A | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 12/10/2024 |
TTWO Take-Two Interactive Software | $183.82
-2.2% | 12/9/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $190.00 | N/A | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 12/9/2024 |
VOR Vor Biopharma | $1.53
+16.8% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 | N/A | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 12/9/2024 |
IRON Disc Medicine | $56.99
-2.6% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $83.00 | N/A | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 12/9/2024 |
BEAM Beam Therapeutics | $26.29
-0.4% | 12/9/2024 | Reiterated by | Wedbush | - | Outperform | $57.00 | N/A | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 12/9/2024 |
EBAY eBay | $64.75
+1.4% | 12/9/2024 | Initiated by | Wedbush | Analyst S. Devitt | Neutral | $70.00 | N/A | View details for Wedbush rating of eBay (NASDAQ:EBAY) on 12/9/2024 |
WOOF Petco Health and Wellness | $3.86
+2.4% | 12/6/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.50 -> $6.00 | N/A | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 12/6/2024 |
GME GameStop | $28.33
+2.5% | 12/6/2024 | Reiterated by | Wedbush | - | Underperform | $10.00 | N/A | View details for Wedbush rating of GameStop (NYSE:GME) on 12/6/2024 |
ROKU Roku | $83.78
+5.3% | 12/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 -> $100.00 | N/A | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 12/6/2024 |
ARE Alexandria Real Estate Equities | $100.36
-0.3% | 12/6/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $120.00 -> $110.00 | N/A | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 12/6/2024 |
CHWY Chewy | $37.99
+2.1% | 12/5/2024 | Reiterated by | Wedbush | - | Outperform | $35.00 -> $39.00 | N/A | View details for Wedbush rating of Chewy (NYSE:CHWY) on 12/5/2024 |
VTR Ventas | $59.46
+1.9% | 12/3/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 | N/A | View details for Wedbush rating of Ventas (NYSE:VTR) on 12/3/2024 |
ARGX argenx | $652.19
+1.9% | 12/3/2024 | Reiterated by | Wedbush | - | Outperform | $655.00 | N/A | View details for Wedbush rating of argenx (NASDAQ:ARGX) on 12/3/2024 |
CVCO Cavco Industries | $476.05
+0.3% | 12/3/2024 | Downgraded by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $480.00 -> $480.00 | N/A | View details for Wedbush rating of Cavco Industries (NASDAQ:CVCO) on 12/3/2024 |
TOL Toll Brothers | $136.58
+0.3% | 12/2/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | N/A | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 12/2/2024 |
NVCR NovoCure | $27.02
+0.7% | 12/2/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral | $24.00 -> $29.00 | N/A | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 12/2/2024 |
RVMD Revolution Medicines | $41.14
+0.5% | 12/2/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 -> $70.00 | N/A | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 12/2/2024 |
APGE Apogee Therapeutics | $40.21
+3.3% | 12/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $87.00 -> $90.00 | N/A | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 12/2/2024 |
UPST Upstart | $69.31
+5.7% | 12/2/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $60.00 -> $75.00 | N/A | View details for Wedbush rating of Upstart (NASDAQ:UPST) on 12/2/2024 |
WDC Western Digital | $68.68
+0.1% | 11/29/2024 | Reiterated by | Wedbush | - | Outperform | $95.00 | N/A | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 11/29/2024 |
AAPL Apple | $223.66
-0.1% | 11/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $300.00 -> $300.00 | N/A | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 11/29/2024 |
PASG Passage Bio | $0.62
+3.6% | 11/29/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $3.00 -> $4.00 | N/A | View details for Wedbush rating of Passage Bio (NASDAQ:PASG) on 11/29/2024 |
VYGR Voyager Therapeutics | $5.53
+1.8% | 11/29/2024 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $7.00 -> $11.00 | N/A | View details for Wedbush rating of Voyager Therapeutics (NASDAQ:VYGR) on 11/29/2024 |
DKS DICK'S Sporting Goods | $246.46
+4.2% | 11/27/2024 | Reiterated by | Wedbush | - | Neutral | $250.00 -> $215.00 | N/A | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 11/27/2024 |
IMAX IMAX | $23.74
+1.1% | 11/27/2024 | Reiterated by | Wedbush | - | Outperform | | N/A | View details for Wedbush rating of IMAX (NYSE:IMAX) on 11/27/2024 |
SRRK Scholar Rock | $45.40
-2.8% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $40.00 -> $47.00 | N/A | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 11/25/2024 |
PLTR Palantir Technologies | $78.98
+2.7% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $57.00 -> $75.00 | N/A | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 11/25/2024 |
CRM Salesforce | $334.75
+0.6% | 11/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $325.00 -> $375.00 | N/A | View details for Wedbush rating of Salesforce (NYSE:CRM) on 11/25/2024 |
DeFi Coin on Verge of Breakout! (Ad) What Smart Crypto Investors Are Doing Differently in 2025
Free book reveals how to navigate and thrive in today’s crypto market…
Request your FREE copy of Crypto Revolution now. |
SNOW Snowflake | $174.77
-1.5% | 11/25/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $190.00 | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 11/25/2024 |
ESTC Elastic | $104.15
+2.9% | 11/25/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $135.00 | N/A | View details for Wedbush rating of Elastic (NYSE:ESTC) on 11/25/2024 |
NTAP NetApp | $126.30
+0.2% | 11/22/2024 | Reiterated by | Wedbush | - | Neutral | $120.00 | N/A | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 11/22/2024 |
CATX Perspective Therapeutics | $3.63
+0.8% | 11/21/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $20.00 -> $11.00 | N/A | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 11/21/2024 |
NVDA NVIDIA | $147.22
+0.1% | 11/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $160.00 -> $175.00 | N/A | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 11/21/2024 |
WSM Williams-Sonoma | $211.79
-0.1% | 11/21/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $135.00 -> $175.00 | N/A | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 11/21/2024 |
SNOW Snowflake | $174.77
-1.5% | 11/21/2024 | Target Raised by | Wedbush | Analyst D. Ives | Neutral -> Neutral | $130.00 -> $160.00 | N/A | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 11/21/2024 |
MSFT Microsoft | $446.71
+0.1% | 11/19/2024 | Reiterated by | Wedbush | Analyst D. Ives | Outperform | $550.00 | N/A | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 11/19/2024 |
FTNT Fortinet | $97.45
-0.8% | 11/19/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $90.00 -> $105.00 | N/A | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 11/19/2024 |
PTGX Protagonist Therapeutics | $37.80
+2.5% | 11/19/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $58.00 | N/A | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 11/19/2024 |
ORKA Oruka Therapeutics | $12.47
-0.2% | 11/19/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $40.00 | N/A | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 11/19/2024 |
NFLX Netflix | $984.86
+3.2% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $800.00 -> $950.00 | N/A | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 11/18/2024 |
SWTX SpringWorks Therapeutics | $36.14
+3.3% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform | $77.00 | N/A | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/18/2024 |
JACK Jack in the Box | $39.21
+0.8% | 11/18/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $60.00 -> $50.00 | N/A | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 11/18/2024 |
NTLA Intellia Therapeutics | $11.29
+2.5% | 11/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $14.00 -> $14.00 | N/A | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/18/2024 |
TSLA Tesla | $412.38
-0.7% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $400.00 -> $400.00 | N/A | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/18/2024 |
CMRX Chimerix | $3.83
+1.3% | 11/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 -> $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 11/18/2024 |
AAP Advance Auto Parts | $47.36
+1.9% | 11/15/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $55.00 -> $55.00 | N/A | View details for Wedbush rating of Advance Auto Parts (NYSE:AAP) on 11/15/2024 |
ASND Ascendis Pharma A/S | $127.49
+1.3% | 11/15/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | $181.00 -> $181.00 | N/A | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/15/2024 |
DIN Dine Brands Global | $30.91
+3.2% | 11/15/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $47.00 -> $47.00 | N/A | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 11/15/2024 |
BPMC Blueprint Medicines | $115.63
+4.1% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform | $135.00 | N/A | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 11/14/2024 |
ANAB AnaptysBio | $16.63
+2.8% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/14/2024 |
CAKE Cheesecake Factory | $51.53
+1.1% | 11/14/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $52.00 -> $59.00 | N/A | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/14/2024 |
NVDA NVIDIA | $147.22
+0.1% | 11/14/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $138.00 -> $160.00 | N/A | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 11/14/2024 |
RUM Rumble | $12.98
+2.9% | 11/13/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $8.00 | N/A | View details for Wedbush rating of Rumble (NASDAQ:RUM) on 11/13/2024 |
RKT Rocket Companies | $11.88
-0.6% | 11/13/2024 | Reiterated by | Wedbush | - | Neutral | $18.00 -> $13.00 | N/A | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 11/13/2024 |
CAVA CAVA Group | $124.14
+0.6% | 11/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $155.00 -> $190.00 | N/A | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 11/13/2024 |
FATE Fate Therapeutics | $1.34
| 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $5.00 | N/A | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 11/12/2024 |
SHOP Shopify | $106.16
-0.2% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $72.00 -> $115.00 | N/A | View details for Wedbush rating of Shopify (NYSE:SHOP) on 11/12/2024 |
SDHC Smith Douglas Homes | $24.39
-1.6% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $20.00 | N/A | View details for Wedbush rating of Smith Douglas Homes (NYSE:SDHC) on 11/12/2024 |
APGE Apogee Therapeutics | $40.21
+3.3% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $87.00 | N/A | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 11/12/2024 |
ITOS iTeos Therapeutics | $7.67
-0.5% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 | N/A | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 11/12/2024 |
IRON Disc Medicine | $56.99
-2.6% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $75.00 -> $83.00 | N/A | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 11/12/2024 |
COGT Cogent Biosciences | $8.89
+8.4% | 11/12/2024 | Reiterated by | Wedbush | - | Neutral | $11.00 | N/A | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 11/12/2024 |
ORIC ORIC Pharmaceuticals | $10.34
+4.8% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 | N/A | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 11/12/2024 |
NUVL Nuvalent | $83.70
+2.9% | 11/12/2024 | Reiterated by | Wedbush | - | Outperform | $115.00 | N/A | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 11/12/2024 |
DDI DoubleDown Interactive | $10.60
+1.4% | 11/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $16.25 -> $21.00 | N/A | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 11/12/2024 |
PINS Pinterest | $32.85
+3.8% | 11/11/2024 | Upgraded by | Wedbush | Analyst S. Devitt | Hold -> Strong-Buy | | N/A | View details for Wedbush rating of Pinterest (NYSE:PINS) on 11/11/2024 |
TSLA Tesla | $412.38
-0.7% | 11/11/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $300.00 -> $400.00 | N/A | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/11/2024 |
STKS ONE Group Hospitality | $3.50
+1.4% | 11/11/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $5.00 -> $3.50 | N/A | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 11/11/2024 |
VOR Vor Biopharma | $1.53
+16.8% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 | N/A | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 11/8/2024 |
SYRE Spyre Therapeutics | $21.81
0.0% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform | $45.00 | N/A | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 11/8/2024 |
CAKE Cheesecake Factory | $51.53
+1.1% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $52.00 -> $52.00 | N/A | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/8/2024 |
EXPE Expedia Group | $176.89
+1.9% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $130.00 -> $180.00 | N/A | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 11/8/2024 |
RIVN Rivian Automotive | $12.49
-1.6% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 -> $20.00 | N/A | View details for Wedbush rating of Rivian Automotive (NASDAQ:RIVN) on 11/8/2024 |
RNG RingCentral | $34.39
+0.9% | 11/8/2024 | Target Raised by | Wedbush | Analyst D. Ives | Neutral -> Neutral | $36.00 -> $41.00 | N/A | View details for Wedbush rating of RingCentral (NYSE:RNG) on 11/8/2024 |
CCSI Consensus Cloud Solutions | $25.83
+1.7% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $24.00 -> $32.00 | N/A | View details for Wedbush rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/8/2024 |
ABNB Airbnb | $133.24
+0.6% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $135.00 -> $155.00 | N/A | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 11/8/2024 |
PINS Pinterest | $32.85
+3.8% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $37.00 -> $38.00 | N/A | View details for Wedbush rating of Pinterest (NYSE:PINS) on 11/8/2024 |
TOST Toast | $39.99
+3.1% | 11/8/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $35.00 -> $45.00 | N/A | View details for Wedbush rating of Toast (NYSE:TOST) on 11/8/2024 |
Vladimir Lenin was right… (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
RDFN Redfin | $8.12
+3.2% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $8.00 -> $10.00 | N/A | View details for Wedbush rating of Redfin (NASDAQ:RDFN) on 11/8/2024 |
TTD Trade Desk | $119.14
-1.3% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $115.00 -> $135.00 | N/A | View details for Wedbush rating of Trade Desk (NASDAQ:TTD) on 11/8/2024 |
FTNT Fortinet | $97.45
-0.8% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $78.00 -> $90.00 | N/A | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 11/8/2024 |
VERA Vera Therapeutics | $34.09
+0.9% | 11/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $30.00 -> $38.00 | N/A | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 11/8/2024 |
GEO The GEO Group | $33.51
-2.5% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $25.00 -> $30.00 | N/A | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 11/8/2024 |
UPST Upstart | $69.31
+5.7% | 11/8/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $45.00 -> $60.00 | N/A | View details for Wedbush rating of Upstart (NASDAQ:UPST) on 11/8/2024 |
PEPG PepGen | $1.95
-1.5% | 11/8/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $19.00 -> $12.00 | N/A | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 11/8/2024 |
VIGL Vigil Neuroscience | $2.35
+15.8% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $23.00 -> $24.00 | N/A | View details for Wedbush rating of Vigil Neuroscience (NASDAQ:VIGL) on 11/8/2024 |
EWTX Edgewise Therapeutics | $27.00
-0.5% | 11/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $44.00 -> $45.00 | N/A | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 11/8/2024 |
TPX Tempur Sealy International | $60.34
-0.5% | 11/8/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $49.00 -> $55.00 | N/A | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 11/8/2024 |
ARHS Arhaus | $12.25
+3.3% | 11/8/2024 | Target Lowered by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $11.00 -> $10.00 | N/A | View details for Wedbush rating of Arhaus (NASDAQ:ARHS) on 11/8/2024 |
PZZA Papa Johns International | $39.88
+5.5% | 11/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 -> $60.00 | N/A | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 11/8/2024 |
GLUE Monte Rosa Therapeutics | $5.50
-0.5% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | N/A | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 11/7/2024 |
ACET Adicet Bio | $0.94
+2.8% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 11/7/2024 |
YOU Clear Secure | $23.99
-2.5% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $24.00 -> $26.00 | N/A | View details for Wedbush rating of Clear Secure (NYSE:YOU) on 11/7/2024 |
TRIP Tripadvisor | $17.93
+13.9% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $16.00 -> $17.00 | N/A | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 11/7/2024 |
CMRX Chimerix | $3.83
+1.3% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | N/A | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 11/7/2024 |
IKNA Ikena Oncology | $1.46
-0.7% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $2.00 | N/A | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 11/7/2024 |
NTLA Intellia Therapeutics | $11.29
+2.5% | 11/7/2024 | Reiterated by | Wedbush | - | Neutral | $14.00 | N/A | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/7/2024 |
FENC Fennec Pharmaceuticals | $6.02
+5.1% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 -> $13.00 | N/A | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 11/7/2024 |
RCUS Arcus Biosciences | $13.32
-0.6% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $36.00 | N/A | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 11/7/2024 |
SWTX SpringWorks Therapeutics | $36.14
+3.3% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $77.00 | N/A | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 11/7/2024 |
GBIO Generation Bio | $0.96
+0.8% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 11/7/2024 |
TTWO Take-Two Interactive Software | $183.82
-2.2% | 11/7/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $190.00 | N/A | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 11/7/2024 |
RITM Rithm Capital | $11.28
+0.1% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 | N/A | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 11/7/2024 |
GHLD Guild | $12.73
+1.0% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $20.00 | N/A | View details for Wedbush rating of Guild (NYSE:GHLD) on 11/7/2024 |
XNCR Xencor | $20.46
-1.0% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $38.00 | N/A | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 11/7/2024 |
MFA MFA Financial | $10.12
+0.5% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | N/A | View details for Wedbush rating of MFA Financial (NYSE:MFA) on 11/7/2024 |
KROS Keros Therapeutics | $12.02
+5.5% | 11/7/2024 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $84.00 | N/A | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 11/7/2024 |
NUVB Nuvation Bio | $2.77
+4.3% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | N/A | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 11/7/2024 |
MELI MercadoLibre | $1,828.73
+0.6% | 11/7/2024 | Reiterated by | Wedbush | - | Outperform | $2,000.00 -> $2,200.00 | N/A | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
APP AppLovin | $362.52
+0.2% | 11/7/2024 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $170.00 -> $270.00 | N/A | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 11/7/2024 |
LYFT Lyft | $13.60
+1.3% | 11/7/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $12.00 -> $20.00 | N/A | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 11/7/2024 |
BROS Dutch Bros | $60.90
+1.1% | 11/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $45.00 -> $55.00 | N/A | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 11/7/2024 |
DIN Dine Brands Global | $30.91
+3.2% | 11/7/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $47.00 -> $47.00 | N/A | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 11/7/2024 |
ANAB AnaptysBio | $16.63
+2.8% | 11/6/2024 | Reiterated by | Wedbush | - | Outperform | $42.00 | N/A | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/6/2024 |
BLDR Builders FirstSource | $168.26
+1.5% | 11/6/2024 | Reiterated by | Wedbush | - | Outperform | $230.00 | N/A | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 11/6/2024 |
LGIH LGI Homes | $91.69
-1.6% | 11/6/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $125.00 | N/A | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 11/6/2024 |
GPRO GoPro | $1.06
-0.9% | 11/6/2024 | Reiterated by | Wedbush | - | Neutral | $1.50 | N/A | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 11/6/2024 |
MLTX MoonLake Immunotherapeutics | $46.88
-0.5% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/4/2024 |
KROS Keros Therapeutics | $12.02
+5.5% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 11/4/2024 |
BMRN BioMarin Pharmaceutical | $62.19
+0.3% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 11/4/2024 |
ASND Ascendis Pharma A/S | $127.49
+1.3% | 11/4/2024 | Upgraded by | Wedbush | Analyst Y. Zhong | Strong-Buy | | Low | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 11/4/2024 |
GFS GlobalFoundries | $41.67
-1.6% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $65.00 -> $60.00 | High | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 11/5/2024 |
INZY Inozyme Pharma | $1.32
+1.5% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 -> $12.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 11/5/2024 |
BEAM Beam Therapeutics | $26.29
-0.4% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $57.00 | High | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 11/5/2024 |
TCRX TScan Therapeutics | $2.56
+1.6% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 11/5/2024 |
WING Wingstop | $288.53
+1.7% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $390.00 -> $390.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 11/5/2024 |
CRSR Corsair Gaming | $9.35
+4.7% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform | $11.00 -> $11.00 | Low | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 11/5/2024 |
MLTX MoonLake Immunotherapeutics | $46.88
-0.5% | 11/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 -> $73.00 | Medium | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/5/2024 |
HMST HomeStreet | $10.41
-2.9% | 11/5/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Outperform | $12.00 | High | View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 11/5/2024 |
APP AppLovin | $362.52
+0.2% | 11/4/2024 | Upgraded by | Wedbush | Analyst M. Pachter | Strong-Buy | | High | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 11/4/2024 |
IDYA IDEAYA Biosciences | $23.29
+0.6% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $52.00 | Medium | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/4/2024 |
SE SEA | $116.44
-1.6% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $84.00 -> $105.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 11/4/2024 |
SAFE Safehold | $16.03
-0.6% | 11/4/2024 | Reiterated by | Wedbush | - | Neutral | $25.00 -> $23.00 | Medium | View details for Wedbush rating of Safehold (NYSE:SAFE) on 11/4/2024 |
WLDN Willdan Group | $37.81
-1.1% | 11/4/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $51.00 | Medium | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 11/4/2024 |
NCMI National CineMedia | $6.76
+0.9% | 11/4/2024 | Reiterated by | Wedbush | - | Neutral | $6.00 -> $7.50 | High | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 11/4/2024 |
SRRK Scholar Rock | $45.40
-2.8% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $37.00 | High | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 11/4/2024 |
CRBP Corbus Pharmaceuticals | $10.79
-4.9% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $51.00 | Medium | View details for Wedbush rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 11/4/2024 |
IRON Disc Medicine | $56.99
-2.6% | 11/4/2024 | Reiterated by | Wedbush | - | Outperform | $60.00 -> $75.00 | High | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 11/4/2024 |
